21 Publikationen in 2024
Kumulativer IF: 216,3
Mittelwert IF: 10,3

1. Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop
Pearce L, Galán-Arriola C, Bell RM, Carr RD, Cunningham J, Davidson SM, Ghosh AK, Giesz S, Golforoush P, Gourine AV, Hermann DM, Heusch G, Ibanez B, Kalkhoran SB, Lecour S, Lukhna K, Ntsekhe M, Sack MN, Unwin RJ, Vilahur G, Walker JM, Yellon DM
Basic Res Cardiol; 10.1007/s00395-024-01094-6    (Impact Factor = 8,0)

2. The multifaceted roles of red blood cells in health and disease
Lieder, HR
Am J Physiol Heart Circ Physiol; 10.1152/ajpheart.00739.2024    (Impact Factor = 4,1)

3. The IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioning
Kleinbongard P, Arriola CG, Badimon L, Crisostomo, V, Giricz Z, Gyöngyösi M, Heusch G, Ibanez B, Kiss A, de Kleijn DPV, Podesser BK, Carracedo RR, Rodríguez-Sinovas A, Ruiz-Meana M, Margallo FMS, Vilahur G, Zamorano JL, Zaragoza C, Ferdinandy P, Hausenloy DJ
Basic Res Cardiol; 10.1007/s00395-024-01083-9    (Impact Factor = 8,0)

4. Deep learning segmentation model for quantification of infarct size in pigs with myocardial ischemia/reperfusion
Braczko F, Skyschally A, Lieder H, Kather JN, Kleinbongard P, Heusch G
Basic Res Cardiol; 10.1007/s00395-024-01081-x    (Impact Factor = 8,0)

5. Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?
Bellofatto IA, Nikolaou PE, Andreadou I, Canepa M, Carbone F, Ghigo A, Heusch G, Kleinbongard P, Maack C, Podesser BK, Stamatelopoulos K, Stellos K, Vilahur G, Montecucco F, Liberale L
Clin Res Cardiol; 10.1007/s00392-024-02522-2    (Impact Factor = 3,7)

6. Cardiac fibroblasts: answering the call
Kleinbongard P, Senyo SE, Lindsey ML, Garvin AM, Simpson JA, de Castro Braz LE.
Am J Physiol Heart Circ Physiol; 327:H681-H686    (Impact Factor = 4,1)

7. Pericytes in the brain and heart: functional roles and response to ischemia and reperfusion.
Dalkara T, Østergaard L, Heusch G, Attwell D
Cardiovasc Res; 10.1093/cvr/cvae147    (Impact Factor = 13,3)

8. Dissemination of the European Society of Cardiology clinical practice guidelines into the National Societies of Cardiology Journals.
Aschermann M, Monsuez JJ, Cinier G; Editors Network of the National Societies of Cardiology Journals
Eur Heart J; 45:3106-3107    (Impact Factor = 35,6)

9. Inhibition of proline-rich tyrosine kinase 2 restores cardioprotection by remote ischaemic preconditioning in type 2 diabetes
Erkens R, Duse DA, Brum A, Chadt A, Becher S, Siragusa M, Quast C, Müssig J, Roden M, Cortese-Krott M, Ibáñez B, Lammert E, Fleming I, Jung C, Al-Hasani H, Heusch G, Kelm M.
Br J Pharmacol; 181:4174-4194    (Impact Factor = 7,7)

10. Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium
Benyó Z, Clementi E, Cremers S, Dávid B, Guzik T, Heusch G, Jarvis M, Orhan K, Seifert R, Tímár J, Ungvari Z, Ferdinandy P
Br J Pharmacol; 181(15):2387-2390    (Impact Factor = 7,7)

11. Vago-splenic signal transduction of cardioprotection in humans
Lieder HR, Paket U, Skyschally A, Rink AD, Baars T, Neuhäuser M, Kleinbongard P, Heusch G
Eur Heart J; 6:ehae250    (Impact Factor = 35,6)

12. Activation of the non-neuronal cholinergic cardiac system by hypoxic preconditioning protects isolated adult cardiomyocytes from hypoxia/reoxygenation injury
Braczko F, Fischl SR, Reinders J, Lieder H, Kleinbongard P
Am J Physiol Heart Circ Physiol; 10.1152/ajpheart.00211.2024    (Impact Factor = 4,1)

13. Mitochondrial Kinase Signaling for Cardioprotection
Boengler K, Eickelmann C, Kleinbongard P
Int J Mol Sci; 25:4491    (Impact Factor = 4,9)

14. 'Expression of concern': publication bias for positive preclinical cardioprotection studies
Skyschally A, Kleinbongard P, Neuhäuser M, Heusch G
Basic Res Cardiol; 119:397-402    (Impact Factor = 8,0)

15. Looking backward to plan forward
Lindsey ML, Kirk JA, LeBlanc AJ, Brunt KR, Carter JR, Hansell Keehan K, Ripplinger CM, Kleinbongard P, Kassiri Z
Am J Physiol Heart Circ Physiol; 326:H1155-H1158    (Impact Factor = 4,1)

16. Is There a Mitochondrial Protection via Remote Ischemic Conditioning in Settings of Anticancer Therapy Cardiotoxicity?
Kleinbongard P, Andreadou I
Curr Heart Fail Rep;    (Impact Factor = 3,1)

17. Cardioprotection research has left its comfort zone
Heusch G, Kleinbongard P
Eur Heart J; 00, 1–3    (Impact Factor = 35,6)

18. The heart of physiological reports
Lindsey ML, Brunt KR, Kleinbongard P, Carter JR, Ripplinger CM, Kassiri Z, Hansell Keehan K, LeBlanc AJ, Kirk JA
Physiol Rep; e15962    (Impact Factor = 1,9)

19. Myocardial ischemia/reperfusion: Translational pathophysiology of ischemic heart disease
Heusch G
Med; 5:10-31    (Impact Factor = 11,8)

20. Reperfusion Injury: How Can We Reduce It by Pre- Per- and Postconditioning
Buske M, Desch S, Heusch G, Rassaf T, Eitel I, Thiele H, Feistritzer HJ
J Clin Med; 13:159    (Impact Factor = 2,9)

21. Differences in vasomotor function of mesenteric arteries between Ossabawminipigs with predisposition to metabolic syndrome and G€ottingen minipigs
Eickelmann C, Lieder HR, Sturek M, Heusch G, Kleinbongard P
Am J Physiol Heart Circ Physiol; H408–H417    (Impact Factor = 4,1)